Immunocore Holdings (IMCR) Capital Expenditures (2021 - 2026)
Immunocore Holdings' Capital Expenditures came in at $786,000 for Q2 2026, up 89.9% from $414,000 a year earlier but down 55.9% from the prior quarter.
Immunocore Holdings (IMCR) Capital Expenditures (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Immunocore Holdings reported Capital Expenditures of $6.2 million, up 20.9% year-over-year; for FY2025, it came in at $4.34 million, down 16.1% from FY2024.
- Capital Expenditures carries a five-year compound annual growth rate of 1.3% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $5.17 million in FY2024 (-4.6%), $5.43 million in FY2023 (+146.3%), $2.2 million in FY2022 (+58.9%) and $1.39 million in FY2021 (-65.9%).
- The five-year range for quarterly Capital Expenditures is $212,000 (Q3 2023) to $3.58 million (Q4 2024).
- Year-over-year, Capital Expenditures increased in five of the last eight quarters, with growth averaging 147.7%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q1 2026 (growth of 497.7%), and the weakest in Q1 2024 (a decline of 85.7%).
- Business Quant data shows IMCR's Capital Expenditures at $1.78 million (Q1 2026), $2.88 million (Q4 2025) and $748,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Immunocore Holdings | 1.56 Bn | -1.92 Bn | 114.84 Mn | 786,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 786,000.00 |
| Mar 31, 2026 | 1.78 Mn |
| Dec 31, 2025 | 2.88 Mn |
| Sep 30, 2025 | 748,000.00 |
| Jun 30, 2025 | 414,000.00 |
| Mar 31, 2025 | 298,000.00 |
| Dec 31, 2024 | 3.58 Mn |
| Sep 30, 2024 | 828,000.00 |
| Jun 30, 2024 | 331,000.00 |
| Mar 31, 2024 | 430,000.00 |
| Dec 31, 2023 | 817,000.00 |
| Sep 30, 2023 | 212,000.00 |
| Jun 30, 2023 | 1.40 Mn |
| Mar 31, 2023 | 3.00 Mn |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 464,348.03 |
| Dec 31, 2021 | 374,746.95 |
Immunocore Holdings Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IMCR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "IMCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IMCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();